A bone marrow harvest is a surgical procedure that collects liquid marrow, rich in blood-forming stem cells, from the back of the pelvic bones while the donor is under anesthesia. It takes about one to two hours, most donors go home the same day or the next, and the body replaces the donated marrow within weeks. The collected cells are used in a stem cell transplant to rebuild the blood and immune system of someone with leukemia, marrow failure, or certain inherited blood diseases.
Below, I walk through how the harvest is done, who it helps, how it compares with blood stem cell collection, and how the field has changed.
What Is a Bone Marrow Harvest?
Bone marrow is the soft tissue inside large bones where all blood cells are made. It contains hematopoietic stem cells, which can divide and mature into red cells, white cells, and platelets for a lifetime. Healthy bone marrow function depends on these cells.
A harvest gathers enough stem cells to repopulate a patient’s marrow. The donor can be the patient themselves (an autologous harvest) or another person, usually a matched sibling, a relative, or a volunteer from a registry (an allogeneic harvest).
The Procedure Step by Step
Before the Harvest
Allogeneic donors are matched to the patient by HLA typing, a blood or cheek-swab test of the immune markers on cells. Close matching lowers the risk of graft-versus-host disease (GVHD), where donor immune cells attack the recipient. The donor then has a full medical check to make sure the procedure is safe for them.
During the Harvest
The donor usually receives general anesthesia, though regional anesthesia is sometimes used. Lying face down, the donor has a hollow needle inserted repeatedly through the skin into the back of the pelvis, the posterior iliac crest, and marrow is drawn into syringes. There are no surgical cuts, only small puncture sites.
The amount collected depends on the size of the recipient and the donor. The marrow is filtered to remove bone fragments and fat, then either given fresh to the recipient or frozen for later use.
Recovery for the Donor
Soreness in the lower back and hips for several days is normal and is managed with simple pain relief. Fatigue is common for a week or two. Most donors return to work or school within about a week, and the marrow fully regenerates in roughly four to six weeks. Serious complications, such as a reaction to anesthesia, infection, or nerve irritation, are uncommon.
| Stage | What happens | Typical timing |
|---|---|---|
| Matching and medical check | HLA typing, blood tests, physical exam | Weeks before |
| Harvest | Marrow drawn from pelvic bones under anesthesia | About 1–2 hours |
| Hospital stay | Observation and pain control | Same day or overnight |
| Return to normal activity | Soreness and tiredness settle | About 1 week |
| Marrow regeneration | Donated marrow fully replaced | About 4–6 weeks |
Clinical Applications: Who Needs a Transplant?
Stem cell transplant is used when the marrow is diseased, failing, or has to be destroyed by intensive treatment. The main groups of blood disorders that may need one are:
- Blood cancers: acute leukemias, myelodysplastic syndromes, some lymphomas, and multiple myeloma.
- Bone marrow failure: severe aplastic anemia and inherited failure syndromes such as Fanconi anemia.
- Inherited red cell diseases: sickle cell disease and thalassemia major, where a transplant can be curative.
- Immune deficiencies and metabolic disorders: such as severe combined immunodeficiency and some storage diseases in children.
In leukemia, an allogeneic transplant does two jobs. It replaces marrow destroyed by high-dose treatment, and the donor’s immune cells can recognize and attack remaining cancer cells, the graft-versus-leukemia effect. These decisions are made by specialist teams familiar with the full range of hematological conditions.
Bone Marrow Harvest vs Peripheral Blood Stem Cell Collection
Today most adult transplants use stem cells collected from the bloodstream rather than directly from the marrow. For a peripheral blood stem cell (PBSC) collection, the donor receives injections of a growth factor, usually G-CSF, for several days. This pushes stem cells out of the marrow into the blood, where a machine collects them through a process called apheresis.
| Feature | Bone marrow harvest | Peripheral blood stem cells |
|---|---|---|
| Anesthesia | Usually general | None |
| Donor preparation | None beyond medical check | Several days of G-CSF injections |
| Donor side effects | Hip and back soreness | Bone aches and flu-like symptoms from G-CSF |
| Speed of engraftment | Somewhat slower | Faster recovery of blood counts |
| Chronic GVHD risk | Lower | Higher |
| Often preferred for | Children, aplastic anemia, some non-cancer diseases | Most adult cancer transplants, autologous transplants |
Because the lower chronic GVHD risk matters most when there is no cancer to fight, marrow is often chosen for aplastic anemia and for children. The transplant team, not the donor, usually decides which source the patient needs.
After the Transplant: Recipient Care
Before receiving the cells, the recipient has conditioning, chemotherapy with or without radiation, to clear diseased marrow cells and suppress the immune system so the graft is accepted. The stem cells are then given through a vein, much like a blood transfusion, and find their own way to the marrow.
Engraftment, when new blood counts start to appear, typically takes two to four weeks. Until then, the patient needs protection from infection, transfusions, and close monitoring for complications such as graft failure and GVHD.
Advancements in the Field
Several well-established developments have widened access to transplant and made it safer:
- Haploidentical transplants: using a half-matched relative, often a parent or child, with post-transplant cyclophosphamide to control GVHD. This means almost every patient now has a potential donor.
- Reduced-intensity conditioning: gentler preparation that allows older or less fit patients to receive a transplant.
- Larger donor registries and cord blood banks: improving the chance of finding an unrelated match, especially for people of diverse ancestry.
- Gene therapy: the patient’s own stem cells are collected, genetically corrected in the lab, and returned. Approved therapies for sickle cell disease and beta thalassemia work this way, removing the need for a donor.
- Better supportive care: improved antifungal and antiviral medicines and more targeted GVHD treatments.
For a wider view of these conditions, see our guide to hematological disorders and our bone marrow guide.
Key Takeaways
- A bone marrow harvest collects stem cells from the pelvic bones under anesthesia in about one to two hours.
- Donors typically recover within a week, and their marrow regenerates within about four to six weeks.
- Transplants treat blood cancers, marrow failure, and inherited diseases such as sickle cell disease.
- Blood stem cell collection is now more common in adults, but marrow remains preferred in some settings.
Frequently Asked Questions
Is donating bone marrow painful?
You are asleep or numb during the harvest, so you feel nothing at the time. Afterward, most donors describe aching in the lower back and hips, similar to a hard fall, which eases over several days.
Does donating bone marrow weaken your own immune system?
No. Only a small fraction of your marrow is taken, and the rest keeps working normally. Your body replaces what was donated within weeks.
How is a bone marrow harvest different from a bone marrow biopsy?
A biopsy removes a small sample to diagnose disease, usually under local anesthetic in minutes. A harvest removes a much larger volume through many punctures to collect enough stem cells for a transplant.
Can you donate bone marrow more than once?
It is possible, and occasionally a donor is asked to give again to the same patient. Registries have safety rules and medical checks that decide whether a second donation is appropriate.
